Storebrand Asset Management’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-38
Closed -$5.77K 815
2025
Q2
$5.77K Hold
38
﹤0.01% 800
2025
Q1
$5.72K Sell
38
-776
-95% -$130K ﹤0.01% 815
2024
Q4
$150K Sell
814
-1,791
-69% -$345K ﹤0.01% 763
2024
Q3
$513K Sell
2,605
-200
-7% -$41.6K ﹤0.01% 720
2024
Q2
$579K Sell
2,805
-993
-26% -$225K ﹤0.01% 710
2024
Q1
$1.03M Hold
3,798
﹤0.01% 684
2023
Q4
$898K Buy
3,798
+307
+9% +$60.4K ﹤0.01% 698
2023
Q3
$684K Sell
3,491
-1,069
-23% -$219K ﹤0.01% 702
2023
Q2
$959K Hold
4,560
﹤0.01% 689
2023
Q1
$920K Buy
4,560
+485
+12% +$110K ﹤0.01% 688
2022
Q4
$888K Sell
4,075
-209
-5% -$45.6K ﹤0.01% 682
2022
Q3
$843K Sell
4,284
-6,334
-60% -$1.37M 0.01% 674
2022
Q2
$2.27M Sell
10,618
-407
-4% -$99.5K 0.01% 585
2022
Q1
$3.13M Sell
11,025
-20,348
-65% -$6.27M 0.01% 563
2021
Q4
$11.8M Buy
31,373
+23,068
+278% +$8.96M 0.05% 352
2021
Q3
$3.43M Buy
8,305
+7,408
+826% +$3.08M 0.02% 581
2021
Q2
$332K Buy
+897
New +$300K ﹤0.01% 776

Other funds holding CRL